GB0820799D0 - Compositions for improved absorption of a therapeutic agent across muscosal membrane or the skin - Google Patents

Compositions for improved absorption of a therapeutic agent across muscosal membrane or the skin

Info

Publication number
GB0820799D0
GB0820799D0 GB0820799A GB0820799A GB0820799D0 GB 0820799 D0 GB0820799 D0 GB 0820799D0 GB 0820799 A GB0820799 A GB 0820799A GB 0820799 A GB0820799 A GB 0820799A GB 0820799 D0 GB0820799 D0 GB 0820799D0
Authority
GB
United Kingdom
Prior art keywords
muscosal
skin
membrane
compositions
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0820799A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Critical Pharmaceuticals Ltd
Original Assignee
Critical Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Critical Pharmaceuticals Ltd filed Critical Critical Pharmaceuticals Ltd
Priority to GB0820799A priority Critical patent/GB0820799D0/en
Publication of GB0820799D0 publication Critical patent/GB0820799D0/en
Priority to BRPI0918253A priority patent/BRPI0918253A2/en
Priority to NZ591261A priority patent/NZ591261A/en
Priority to RU2011114078/15A priority patent/RU2519193C2/en
Priority to GB0916028A priority patent/GB2463565A/en
Priority to MX2011002688A priority patent/MX2011002688A/en
Priority to EP09785642A priority patent/EP2334285A1/en
Priority to AU2009290656A priority patent/AU2009290656B2/en
Priority to CA2734381A priority patent/CA2734381A1/en
Priority to PCT/GB2009/051188 priority patent/WO2010029374A1/en
Priority to KR1020117006348A priority patent/KR20110056516A/en
Priority to US13/063,411 priority patent/US8795634B2/en
Priority to JP2011526574A priority patent/JP6002385B2/en
Priority to CN200980135458.5A priority patent/CN102149368B/en
Priority to IL211328A priority patent/IL211328A0/en
Priority to ZA2011/01638A priority patent/ZA201101638B/en
Priority to US14/080,486 priority patent/US20140072588A1/en
Priority to JP2014243440A priority patent/JP2015042689A/en
Ceased legal-status Critical Current

Links

GB0820799A 2008-09-12 2008-11-13 Compositions for improved absorption of a therapeutic agent across muscosal membrane or the skin Ceased GB0820799D0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
GB0820799A GB0820799D0 (en) 2008-11-13 2008-11-13 Compositions for improved absorption of a therapeutic agent across muscosal membrane or the skin
CN200980135458.5A CN102149368B (en) 2008-09-12 2009-09-14 Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
CA2734381A CA2734381A1 (en) 2008-09-12 2009-09-14 Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
KR1020117006348A KR20110056516A (en) 2008-09-12 2009-09-14 Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
RU2011114078/15A RU2519193C2 (en) 2008-09-12 2009-09-14 Improving absorption of therapeutic agents through mucous membranes or skin
GB0916028A GB2463565A (en) 2008-09-12 2009-09-14 Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
MX2011002688A MX2011002688A (en) 2008-09-12 2009-09-14 Improvements in the absorption of therapeutic agents across mucosal membranes or the skin.
EP09785642A EP2334285A1 (en) 2008-09-12 2009-09-14 Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
AU2009290656A AU2009290656B2 (en) 2008-09-12 2009-09-14 Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
BRPI0918253A BRPI0918253A2 (en) 2008-09-12 2009-09-14 improved absorption of therapeutic agents through mucous membranes or skin
PCT/GB2009/051188 WO2010029374A1 (en) 2008-09-12 2009-09-14 Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
NZ591261A NZ591261A (en) 2008-09-12 2009-09-14 Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
US13/063,411 US8795634B2 (en) 2008-09-12 2009-09-14 Absorption of therapeutic agents across mucosal membranes or the skin
JP2011526574A JP6002385B2 (en) 2008-09-12 2009-09-14 Pharmaceutical composition, method for using absorption enhancer in pharmaceutical composition, and method for producing pharmaceutical composition
IL211328A IL211328A0 (en) 2008-09-12 2011-02-21 Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
ZA2011/01638A ZA201101638B (en) 2008-09-12 2011-03-03 Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
US14/080,486 US20140072588A1 (en) 2008-09-12 2013-11-14 Absorption of therapeutic agents across mucosal membranes or the skin
JP2014243440A JP2015042689A (en) 2008-09-12 2014-12-01 Pharmaceutical compositions, method of using absorption enhancers in pharmaceutical compositions, and method of producing pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0820799A GB0820799D0 (en) 2008-11-13 2008-11-13 Compositions for improved absorption of a therapeutic agent across muscosal membrane or the skin

Publications (1)

Publication Number Publication Date
GB0820799D0 true GB0820799D0 (en) 2008-12-24

Family

ID=40194588

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0820799A Ceased GB0820799D0 (en) 2008-09-12 2008-11-13 Compositions for improved absorption of a therapeutic agent across muscosal membrane or the skin

Country Status (1)

Country Link
GB (1) GB0820799D0 (en)

Similar Documents

Publication Publication Date Title
IL249941A0 (en) Spiro-oxindole compounds and their use as therapeutic agents
IL250435A0 (en) Use of human hil-2-mutein for the preparation of an agent for the formation of regulatory t-cells
HK1211889A1 (en) Therapeutic use of diaminophenothiazines
EP2251064A4 (en) Sanitary mask for the protection of others
ZA201101638B (en) Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
EP2120757A4 (en) Thermochemical ablation of bodily tissue
EP2308493A4 (en) Ameliorating or therapeutic agent for dyslipidemia
IL203051A (en) Use of alpha-ketoglutarate for the preparation of medicaments
GB0715556D0 (en) Improvements relating to skin dressings
GB0921075D0 (en) Novel combination of the therapeutic agents
HK1156867A1 (en) External preparation for skin
IL211313A0 (en) Compounds, compositions and methods for the treatment of ??-amyloid diseases and synucleinopathies
GB2458228B (en) External preparation for skin
EP2209458A4 (en) Skin treatment compositions
EP2091486A4 (en) Skin friendly diaper
EP2039340A4 (en) Skin cleansing composition
ZA201101821B (en) 1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin deases
PL2323625T3 (en) New composition for the treatment of ecchymotic pigmentations
EP2157089A4 (en) The therapeutic uses of imidazol-5-carboxylic acid derivatives
EP2062588A4 (en) Composition for amelioration of skin condition
GB0820799D0 (en) Compositions for improved absorption of a therapeutic agent across muscosal membrane or the skin
TWI371289B (en) Mixture for skin care
ZA201007839B (en) Therapeutic agent for pain
GB0816642D0 (en) Compositions for Improved Absorption of a Therapeutic Agent across a Mucosal Membrane
IL178853A0 (en) Tar composition for the treatment of skin diseases

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)